Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OSIMERTINIB Cause Clostridium difficile infection? 15 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Clostridium difficile infection have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.1% of all adverse event reports for OSIMERTINIB.

15
Reports of Clostridium difficile infection with OSIMERTINIB
0.1%
of all OSIMERTINIB reports
3
Deaths
11
Hospitalizations

How Dangerous Is Clostridium difficile infection From OSIMERTINIB?

Of the 15 reports, 3 (20.0%) resulted in death, 11 (73.3%) required hospitalization, and 1 (6.7%) were considered life-threatening.

Is Clostridium difficile infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OSIMERTINIB. However, 15 reports have been filed with the FAERS database.

What Other Side Effects Does OSIMERTINIB Cause?

Death (10,423) Malignant neoplasm progression (2,920) Diarrhoea (1,408) Drug resistance (1,026) Fatigue (819) Rash (772) Decreased appetite (706) Drug ineffective (627) Dyspnoea (621) Nausea (610)

What Other Drugs Cause Clostridium difficile infection?

ADALIMUMAB (1,502) INFLIXIMAB (1,419) VEDOLIZUMAB (1,130) LENALIDOMIDE (814) VANCOMYCIN (743) METRONIDAZOLE (619) PREDNISONE (618) METHOTREXATE (588) RITUXIMAB (532) CIPROFLOXACIN (508)

Which OSIMERTINIB Alternatives Have Lower Clostridium difficile infection Risk?

OSIMERTINIB vs OSPEMIFENE OSIMERTINIB vs OSPHENA OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB OSIMERTINIB vs OXACILLIN OSIMERTINIB vs OXALIPLATIN

Related Pages

OSIMERTINIB Full Profile All Clostridium difficile infection Reports All Drugs Causing Clostridium difficile infection OSIMERTINIB Demographics